GYREGyre Therapeutics, Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−17% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 17). Price is −17% vs its 200-day average.
Lightly shorted, settled Sep 30, 2026, about a week of normal trading to cover.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How GYRE is trading
Gyre Therapeutics, Inc. is −26% over the past year while the S&P 500 is +16%: 42 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −17%
vs 200-day average · a clear downtrend
- RSI (14)
- 17
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 33%
Below its 52-week high
Details›
- Last close2026-10-23
- $5.85
- 1 monthS&P 500 −0.94%
- −20%
- 1 yearS&P 500 +16%
- −26%
- 5 yearsS&P 500 +86%
- −40%
- vs 50-day average$6.81
- −14%
- 52-week high
- $8.76
- 52-week low
- $5.56
- Annualised volatility
- 75%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $870K
| Year | Return |
|---|---|
| 2026 (year to date) | −17% |
| 2025 | −42% |
| 2024 | −53% |
| 2023 | +422% |
| 2022 | +122% |
| 2021 | −86% |
| 2020 | −7.3% |
| 2019 | −14% |
| 2018 | −42% |
| 2017 | +40% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −1.2% |
| Feb | 10 | 6 of 10 | +3.1% |
| Mar | 10 | 3 of 10 | −8.5% |
| Apr | 10 | 5 of 10 | +1.2% |
| May | 10 | 3 of 10 | +7.5% |
| Jun | 10 | 5 of 10 | +2.2% |
| Jul | 11 | 3 of 11 | −2.3% |
| Aug | 11 | 7 of 11 | +4.0% |
| Sep | 11 | 3 of 11 | −1.7% |
| Oct | 11 | 5 of 11 | −3.9% |
| Nov | 10 | 6 of 10 | +25% |
| Dec | 10 | 4 of 10 | +5.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.